Stool Screening for Campylobacter Species in Hypogammaglobulinemic Patients Receiving Immunoglobulin Therapy
Authors:
Open Access
- 16 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 45 (1) , 1-10
Abstract
Hypogammaglobulinemia (HG) predisposes patients to gastrointestinal Campylobacter infections. This prospective study determined the prevalence of Campylobacter in stool samples from patients with immunoglobulin (Ig)-substituted HG at Bordeaux University Hospital. 73 patients (42 women, median age: 61) receiving Ig substitution therapy were enrolled from July 2022 to July 2024. Stool samples were analysed with culture, PCR, faecal calprotectin levels, and immune profiles were also assessed. A second stool sample was collected from 38 patients after 6–12 months, totalling 111 samples. 53 patients had primary HG (32 common variable immunodeficiency, 7 IgG subclass deficiencies, 4 Bruton’s agammaglobulinemias) and 20 had secondary HG (7 drug-induced, 8 lymphoid hemopathy-related, 5 mixed). Campylobacter were detected in 11 patients (15.1%), with species identified as Campylobacter jejuni, Campylobacter coli, and Aliarcobacter butzleri. Diarrhea was reported in 42% of Campylobacter-positive patients versus 15% of negative patients. Campylobacter-positive patients exhibited higher median faecal calprotectin levels (255 µg/g vs. 52 µg/g). Among positive patients, 44% (versus 34% in negative patients) had non-infectious complications such as immune complications. Mean residual IgG levels were similar between groups, although IgA and IgM were lower in Campylobacter-positive patients (0 vs. 0.36 g/L and 0.17 vs. 0.40 g/L, respectively). The mean CD4/CD8 ratio was also lower in the positive group (1.71 ± 0.85 vs. 2.06 ± 1.18). This study reveals a high prevalence of Campylobacter in HG patients despite receiving Ig therapy. Elevated faecal levels of calprotectin in symptomatic patients suggests active infection. Screening for Campylobacter should be considered in HG patients presenting with digestive symptoms.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: A UK national case-series and review of the literatureThe Journal of Allergy and Clinical Immunology: In Practice, 2023
- Prokka: rapid prokaryotic genome annotationBioinformatics, 2014
- RelapsingCampylobacter jejuniSystemic Infections in a Child with X-Linked AgammaglobulinemiaCase Reports in Pediatrics, 2013
- Identification of Campylobacter species and related organisms by matrix assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometryClinical Microbiology and Infection, 2011
- High Prevalence of Intestinal Carriage of Campylobacter coli in Patients With Primary Antibody DeficienciesJournal of Clinical Gastroenterology, 2011
- Campylobacter BacteremiaMedicine, 2010
- Inferring weak population structure with the assistance of sample group informationMolecular Ecology Resources, 2009
- Infections in 252 Patients with Common Variable ImmunodeficiencyClinical Infectious Diseases, 2008
- Common Variable Immunodeficiency: Clinical and Immunological Features of 248 PatientsClinical Immunology, 1999
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997